Rotman Harris - Insider Non-Derivative Transactions at Centessa Pharmaceuticals plc (CNTA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 1, 2024, Rotman Harris's relationship to Centessa Pharmaceuticals plc (CNTA) is Officer (SVP Regulatory Affairs), and currently has 71,000 shares of Ordinary Shares.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CNTA insiders.
Data Source: SEC.
Rotman Harris - Insider Non-Derivative Transactions of CNTA Ordinary Shares
Rotman Harris - Insider Non-Derivative Transactions at CNTA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 2, 2024 | Sell -- (Ordinary Shares) | 4267 | 8.1 | 62625 |
| Feb 2, 2024 | F -- (Ordinary Shares) | 4108 | 8.19 | 66892 |
| Feb 2, 2024 | Acquisition -- (Ordinary Shares) | 37500 | 0 | 71000 |
| Sep 21, 2023 | Sell -- (Ordinary Shares) | 37484 | 6.29 | 33500 |
| Sep 21, 2023 | M -- (Ordinary Shares) | 31250 | 4.47 | 64750 |
| Sep 21, 2023 | M -- (Ordinary Shares) | 6234 | 3.85 | 70984 |